Advertisement

Topics

Latest "Human Genome Sequencing centerBaylor college of Medicine" News Stories

08:42 EST 23rd January 2019 | BioPortfolio

Here are the most relevant search results for "Human Genome Sequencing centerBaylor college of Medicine" found in our extensive news archives from over 250 global news sources.

More Information about Human Genome Sequencing centerBaylor college of Medicine on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Human Genome Sequencing centerBaylor college of Medicine for you to read. Along with our medical data and news we also list Human Genome Sequencing centerBaylor college of Medicine Clinical Trials, which are updated daily. BioPortfolio also has a large database of Human Genome Sequencing centerBaylor college of Medicine Companies for you to search.

Showing "Human Genome Sequencing centerBaylor college Medicine" News Articles 1–25 of 16,000+

Wednesday 23rd January 2019

DirectPath Appoints Health Care Industry Expert Marc Salois to Chief Revenue Officer

Salois to lead sales team to develop relationships with broker partners and employer clients DirectPath, the industry leader in personalized benefits education, health care transparency and tax-advantaged reimbursement plan administration, today announced that it has appointed Marc Salois as Chief Revenue Officer. With nearly 30 years


ForceBrands Launches HerbForce Executive Recruitment Services and Job Board for the Cannabis Sector

The specialized division will offer executive search services, board of director assembly, and a digital job board ForceBrands, the leading specialized recruiting firm for the consumer products industry, today announced the launch of its cannabis-focused division, HerbForce. HerbForce, offering white glove executive search services and a digital ...

With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs. https://buff.ly/2Ubm1MG 

With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs. https://buff.ly/2Ubm1MG 


InGeneron Expands Development Pipeline with Two Osteoarthritis Programs

Company enrolls first patients in feasibility studies for chronic back pain and wrist osteoarthritis, setting clinical development focus on orthopedic indications InGeneron, Inc., a regenerative medicine and cell therapy company, announced today the enrollment of the first patients in two new feasibility studies evaluating InGeneron’s regenerative ce...

CAMP4 Therapeutics Announces Rare Disease Research Collaboration with Alnylam

--Collaboration will leverage CAMP4’s Gene Circuitry Platform™ to rapidly identify novel signaling pathway targets for potential RNAi intervention-- CAMP4 Therapeutics today announced a research collaboration with Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) focused on identifying new druggable targets to address an undisclosed rare disease of the ...

Arcadia Biosciences to Present at NobleConXV, 15th Annual Investor Conference January 28-29, 2019

Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient company, today announced that it will be featured as a presenting company at NobleConXV, Noble Capital Markets’ Fifteenth Annual Investor Conference, at the W Hotel in Fort Lauderdale, Florida. Raj Ketkar, Arcadia’s president and CEO, will present a business overview at 1:...

Wall Street Veteran Keith L. Horn Joins Stillwater Board of Directors

Horn Brings Decades of Business Acumen in Finance, Investment, Management and More to Board Stillwater, Colorado’s leading company for the processing, manufacturing and distribution of soluble cannabinoid-infused consumer packaged goods and commercial food, beverage and cosmetic ingredients, today announces the appointment of Keith L. Horn to ...

Twist Bioscience Receives ISO 13485:2016 and 9001:2015 Certifications of its Quality Management Systems for NGS Target Enrichment Panels

-- Expands Potential Serviceable Market to Include Companies Requiring Certification -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that its quality management systems for manufacturing its next-generation sequencing (NGS) Target Enrichment Pane...

SentryHealth, Johns Hopkins HealthCare Sign 5-Year Agreement

Collaboration enables SentryHealth to bring Johns Hopkins Medicine Employee Health Programs to Self-Insured Employers SentryHealth, an innovative Louisville-based healthcare company formerly known as Edumedics, today announced a 5-year agreement with Johns Hopkins HealthCare, LLC to be an authorized distributor and worksite provider of employee health ...

Local Waco, TX, Dentist Applies Total Health Academy’s Comprehensive, Whole-Body Approach to Dentistry

Waco, TX, dentists Drs. Donna G. Miller, Michelle Hinds, Austin Green and their dental team at Creekwood Dental Arts, have now been implementing the Total Health Academy’s comprehensive, whole-body education program at their dental practice for one year. WACO, Texas (PRWEB) January 23, 2019 Drs. Donna G. Miller, Michelle Hinds and Austin Green of Creekwood Dental Arts have proudly announced tha...

Leading Periodontists in New London, CT, Announce 2019 Shoreline Periodontics Synergy Study Club and Hygiene Study Club Schedules

Drs. Gregory Toback and Marianne Urbanski, leading periodontists serving New London, CT and Westerly, RI, have announced the release of Shoreline Periodontics’ Synergy Study Club and Hygiene Study Club schedules. These continuing education courses encourage further research and refined skill among area dental professionals. New London, CT (PRWEB) January 23, 2019 Drs. Gregory Toback and Mariann...

Publishing of Orion Corporation's Financial Statement Release for 2018 on 6 February 2019

ORION CORPORATION                    PRESS RELEASE                   23 JANUARY 2019 at 13.30 EET  Publishing of Orion Corporation's Financial Statement Release for 2018 on 6 February 2019 Orion will publish its Financial Statement Release for 2018 on Wednesday, 6 February 2019 approximately at 12.00 noon Finnish time (EET)....

rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes

This patent enables rHEALTH's unique technology to measure many analytes in a given small volume of sample at home or in the clinic CAMBRIDGE, Mass. (PRWEB) January 23, 2019 rHEALTH LLC, an innovative digital health solutions company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/682,010...

Human Rabies--Virginia, 2017

This fatal case of rabies after a dog bite sustained on a trip to India underscores the importance of obtaining a thorough pretravel health consultation and accurate, timely postexposure diagnosis. Morbidity & Mortality Weekly Report

Degree of Control of Patients With COPD

How successful are COPD patients at controlling symptoms and managing their disease? The SINCON study provides some insight. BMC Pulmonary Medicine

Dr. Yong-Beom Park’s Research in Cartilage Regeneration Earns Him Young Investigator Award

Yong-Beom Park, M.D., Ph.D., is named the STEM CELLS Translational Medicine’s Young Investigator of 2018 for his research in cartilage regeneration in osteoarthritic patients. DURHAM, N.C. (PRWEB) January 23, 2019 Yong-Beom Park, M.D., Ph.D., is named the STEM CELLS Translational Medicine’s Young Investigator of 2018 for his research in cartilage regeneration in osteoarthritic patients. The a...

$AMRN New REDUCE-IT™ Trial Data Showing the Total Reduction in Ischemic Events Accepted for Presentation at the American College of Cardiology’s 68th Annual Scientific Session https://finance.yahoo.com/news/reduce-trial-data-showing-total-110000624.

$AMRN New REDUCE-IT™ Trial Data Showing the Total Reduction in Ischemic Events Accepted for Presentation at the American College of Cardiology’s 68th Annual Scientific Session https://finance.yahoo.com/news/reduce-trial-data-showing-total-110000624.html …

New Study Shows Supplementation with Nicotinamide Riboside (NR) During Breastfeeding Yields Measurable, Lasting Benefits to Mothers and Offspring in Animal Model

Landmark preclinical lactation study of unique form of vitamin B3 (nicotinamide riboside) showing remarkable results in rodents published in Cell Reports ChromaDex Corp. (NASDAQ:CDXC) today reported that results of a first-of-a-kind preclinical study on lactation have shown that supplementation with the unique B3 vitamin nicotinamide riboside (NR, or ...

Co-Diagnostics, Inc. CoPrimer™ Platform Featured at PAG XXVII Conference

Presentation coincided with launch of a private-label CoPrimer product Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that their CoPrimer™ platform was featured in presentations at the International Plant and Genome confere...

With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs

With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs.

Aspirin use associated with reduction in cardiovascular events but increase in bleeding risk

1. In this systematic review and meta-analysis, while aspirin use among patients without cardiovascular disease was associated with fewer adverse cardiovascular events, it was not associated with a reduction in all-cause mortality. 2. The use of aspirin in patients without cardiovascular disease was associated with increased risk of major bleeding. Evidence Rating Level: 1 (Excellent) Study [R...

STEMCELL Technologies Launches mTeSR™ Plus, a Next-Generation Culture System for Human ES and iPS Cell Maintenance

STEMCELL Technologies has released mTeSR™ Plus, an enhanced version of mTeSR™1, the most widely published

Ozempic launched for type II diabetes in the UK

Novo Nordisk has announced that Ozempic, a new once-weekly GLP-1 (human glucagon-like peptide-1) analogue injection for the treatment of type II diabetes, is now available in the UK.

Including prices on TV ads only works when the price is listed alone

Requiring pharmaceutical companies to publish the price of their drugs on adverts on TV, would probably not help to control drug prices, according to a study published in the journal JAMA Internal Medicine. While price disclosure did deter potential customers from asking about highly priced drugs, when patients viewed adverts for highly priced drugs containing a ‘modifier’ – suggesting that ...

BioNTech to Acquire Antibody Generation Unit of MAB Discovery

BioNTech AG, a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases, and MAB Discovery GmbH, a unique player in the generation and development of sophisticated and therapeutically relevant monoclonal antibodies (mAbs), today announced that both part...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks